Targeting the SWI/SNF Chromatin Remodeling Complex Subunit SMARCA4 in ALL. Read more about Targeting the SWI/SNF Chromatin Remodeling Complex Subunit SMARCA4 in ALL.
PKCd-Mediated Phosphorylation of CD25 Initiates Feedback Control of Oncogenic Tyrosine Kinases in Acute Lymphoblastic Leukemia. Read more about PKCd-Mediated Phosphorylation of CD25 Initiates Feedback Control of Oncogenic Tyrosine Kinases in Acute Lymphoblastic Leukemia.
KMT2A -Rearranged ALL Requires DYRK1A for Regulation of ERK Signaling and Cell Proliferation. Read more about KMT2A -Rearranged ALL Requires DYRK1A for Regulation of ERK Signaling and Cell Proliferation.
Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia. Read more about Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia.
Differential Gene Expression in KMT2A::AFF1 Leukemia Is Driven By Enhancer Heterogeneity. Read more about Differential Gene Expression in KMT2A::AFF1 Leukemia Is Driven By Enhancer Heterogeneity.
CD48: Friend or Foe in NK-Cell Immunosurveillance of Multiple Myeloma?. Read more about CD48: Friend or Foe in NK-Cell Immunosurveillance of Multiple Myeloma?.
BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models. Read more about BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models.
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Read more about BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Read more about MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
